GnRH agonist administration as luteal support on the transfer day of single blastocyst in dual-triggered cycles.

Our study demonstrated that in dual triggered cycles administration of a single dose of GnRH-a on the transfer day of a single blastocyst in addition to routine luteal phase support with progesterone does not statistically increase implantation, clinical pregnancy or live birth rates.